Insulet is trading at $147.62, up 4.03%, with the move appearing most consistent with healthcare-sector strength.

  • Healthcare is up 1.35%, while the broader market is lower.
  • No clearly verified Insulet-specific catalyst directly explains the October 22 move.
  • The Omnipod Discover U.S. launch was announced October 12, not October 22, so it is not a fresh announcement today.